相关实验视频

Updated: Jun 28, 2025

Preparation of Tumor Antigen-loaded Mature Dendritic Cells for Immunotherapy

Preparation of Tumor Antigen-loaded Mature Dendritic Cells for Immunotherapy

Published on: August 1, 2013

基于树突细胞的免疫疗法:树突细胞迁移的重要性

Min-Seon Song¹, Ji-Hee Nam¹, Kyung-Eun Noh¹

¹Department of Bioconvergence, Graduate School and Department of Biotechnology, CHA University, 335 Pangyo-ro, Bundang-gu, Seongnam-si, Gyeonggi-do 13488, Republic of Korea.

Journal of immunology research

|April 17, 2024

概括

增强树突细胞 (DC) 到淋巴结的迁移是改善基于DC的免疫治疗的关键. 本综述探讨了DC迁移的情况.

科学领域:

免疫学免疫学免疫学
癌症免疫疗法癌症免疫疗法

背景情况:

树突细胞 (DCs) 是对免疫反应和自我耐受性至关重要的抗原呈现细胞.
基于DC的免疫疗法显示出希望,但面临着诸如免疫逃脱和有限的DC迁移等挑战.
低数量的迁移性DC (5-10%) 到达淋巴结阻碍了治疗疗效.

研究的目的:

审查树突细胞迁移在免疫治疗中的关键作用.
讨论当前关于增强DC迁移的研究,以改善治疗结果.

主要方法:

树突细胞生物学和迁移的文献综述.
分析基于直流的免疫疗法的挑战和进展.
综合研究关于增加迁徙DC人口的战略.

主要成果:

树突细胞迁移到淋巴结是DC免疫疗法中速度限制的步骤.
促进DC迁移的策略可以显著增强抗瘤免疫力.
了解迁移机制对于优化基于DC的疗法至关重要.

结论:

增加迁移性树突细胞的数量对于推进基于直流的免疫疗法至关重要.
对DC迁移途径的进一步研究可以克服当前的治疗限制.
优化DC迁移有可能为对抗各种疾病提供更有效的治疗方法.

更多相关视频

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Published on: February 24, 2023

Chemical Conjugation of a Purified DEC-205-Directed Antibody with Full-Length Protein for Targeting Mouse Dendritic Cells In Vitro and In Vivo

Chemical Conjugation of a Purified DEC-205-Directed Antibody with Full-Length Protein for Targeting Mouse Dendritic Cells In Vitro and In Vivo

Published on: February 5, 2021

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

T Cell Activation and Clonal Selection

T Cell Activation and Clonal Selection

T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...